NASDAQ:SHLT SHL Telemedicine (SHLT) Stock Price, News & Analysis → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free SHLT Stock Alerts $5.42 +0.32 (+6.27%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$5.42▼$5.5050-Day Range$4.07▼$6.7052-Week Range$4.06▼$12.75Volume881 shsAverage Volume2,780 shsMarket Capitalization$79.57 millionP/E RatioN/ADividend YieldN/APrice Target$11.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get SHL Telemedicine alerts: Email Address SHL Telemedicine MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside103.0% Upside$11.00 Price TargetShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.29Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 starsMedical Sector513th out of 918 stocksHealth Information Services Industry2nd out of 4 stocks 3.5 Analyst's Opinion Consensus RatingSHL Telemedicine has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSHL Telemedicine has only been the subject of 1 research reports in the past 90 days.Read more about SHL Telemedicine's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of SHL Telemedicine have been sold short.Short Interest Ratio / Days to CoverSHL Telemedicine has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SHL Telemedicine has recently decreased by 92.31%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSHL Telemedicine does not currently pay a dividend.Dividend GrowthSHL Telemedicine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SHLT. Previous Next 1.8 News and Social Media Coverage News SentimentSHL Telemedicine has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for SHL Telemedicine this week, compared to 1 article on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SHL Telemedicine insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 20.11% of the stock of SHL Telemedicine is held by institutions.Read more about SHL Telemedicine's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioSHL Telemedicine has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about SHL Telemedicine's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some About SHL Telemedicine Stock (NASDAQ:SHLT)SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.Read More SHLT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHLT Stock News HeadlinesMay 21 at 1:45 AM | businesswire.comSHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood TestMay 17, 2024 | morningstar.comSHL Telemedicine Ltd ADR - NewMay 16, 2024 | finance.yahoo.comSHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft LaunchMay 16, 2024 | businesswire.comSHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft LaunchApril 17, 2024 | finanznachrichten.deSHL Telemedicine Ltd.: SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical MilestonesApril 17, 2024 | finance.yahoo.comSHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical MilestonesApril 16, 2024 | finance.yahoo.comSHL Telemedicine Ltd. (SHLT)April 11, 2024 | msn.comTelehealth clinical trial cuts hospital cardiac readmissions by 76%April 11, 2024 | finance.yahoo.comImperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient CareApril 11, 2024 | businesswire.comImperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient CareApril 8, 2024 | finance.yahoo.comSHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 ExperimentApril 8, 2024 | businesswire.comSHL Telemedicine's SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 ExperimentApril 5, 2024 | businesswire.comSHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023March 14, 2024 | businesswire.comSHL Telemedicine Receives Buy Rating with $11.00 Price TargetFebruary 1, 2024 | finance.yahoo.comImperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24December 23, 2023 | morningstar.comSHL Telemedicine Ltd ADR - New SHLTDecember 19, 2023 | finance.yahoo.comSHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024November 27, 2023 | businesswire.comSHL Telemedicine Introduces SmartHeart ® Direct-to-Consumer Membership Plan in the USNovember 27, 2023 | finance.yahoo.comSHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the USNovember 7, 2023 | msn.comSHL Telemedicine launches network of cardiologists in the USNovember 6, 2023 | benzinga.comIndustry Report: SHL Telemedicine is Emerging as a Potential Game Changer in U.S. Healthcare and TelemedicineNovember 6, 2023 | finance.yahoo.comSHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth VisitsSeptember 29, 2023 | finanznachrichten.deSHL Telemedicine Ltd.: SHL Telemedicine's SmartHeart Technology to Take Center Stage at Upcoming VPM 2023 ConferenceSeptember 26, 2023 | finance.yahoo.comSHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London TrialsSeptember 26, 2023 | businesswire.comSHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London TrialsSee More Headlines Receive SHLT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SHL Telemedicine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/20/2024Next Earnings (Estimated)7/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:SHLT CUSIPN/A CIK1166834 Webwww.shl-telemedicine.com Phone972-3-561-2212FaxN/AEmployees583Year FoundedN/APrice Target and Rating Average Stock Price Target$11.00 High Stock Price Target$11.00 Low Stock Price Target$11.00 Potential Upside/Downside+103.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.20 Current Ratio2.30 Quick Ratio2.10 Sales & Book Value Annual Sales$57.08 million Price / Sales1.39 Cash Flow$0.05 per share Price / Cash Flow117.75 Book Value$5.21 per share Price / Book1.04Miscellaneous Outstanding Shares14,680,000Free FloatN/AMarket Cap$79.57 million OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Erez Nachtomy (Age 62)Chief Executive Officer Comp: $394.26kMr. Amir Hai (Age 58)Chief Financial Officer Mr. Linus Drop (Age 51)Co-Managing Director of SHL Telemedizin Germany Mr. Bernd AltpeterCo-Managing Director of SHL Telemedizin GermanyKey CompetitorsOncology InstituteNASDAQ:TOIPono Capital TwoNASDAQ:PTWOHyperfineNASDAQ:HYPRMural OncologyNASDAQ:MURASEP AcquisitionNASDAQ:SEPAView All Competitors SHLT Stock Analysis - Frequently Asked Questions Should I buy or sell SHL Telemedicine stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SHL Telemedicine in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SHLT shares. View SHLT analyst ratings or view top-rated stocks. What is SHL Telemedicine's stock price target for 2024? 1 analysts have issued 1-year price objectives for SHL Telemedicine's shares. Their SHLT share price targets range from $11.00 to $11.00. On average, they expect the company's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 103.0% from the stock's current price. View analysts price targets for SHLT or view top-rated stocks among Wall Street analysts. How have SHLT shares performed in 2024? SHL Telemedicine's stock was trading at $7.98 at the beginning of the year. Since then, SHLT shares have decreased by 32.1% and is now trading at $5.42. View the best growth stocks for 2024 here. When is SHL Telemedicine's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 17th 2024. View our SHLT earnings forecast. How do I buy shares of SHL Telemedicine? Shares of SHLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SHLT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts4 Cryptos BETTER than BitcoinTrue Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SHL Telemedicine Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
